Image based counting of CLL cells at VE-Cadherin junctions or > 1μm within caveolin-1 in TEM assays revealed an increased frequency of the later under ephrinA4Fc treatments (Figure 6C-iii) in concert with an enhanced TC pathway through the endothelial cell body. This evidence concerns the gene CAV1 and B-cell chronic lymphocytic leukemia.